Figure 5

Confocal Microscopic validation of synergism between soluble curcumin and vancomycin over multidrug resistant clinical Klebsiella pneumoniae. (a) Untreated Klebsiella pneumoniae at t = 0 h. (b) Untreated Klebsiella pneumoniae at t = 18 h. (c) Soluble curcumin (8 µg/ml) treated Klebsiella pneumoniae at t = 18 h. (d) Vancomycin treated (512 µg/ml) treated Klebsiella pneumoniae at t = 18 h. (e) Soluble curcumin (8 µg/ml) and vancomycin (2 µg/ml) treated Klebsiella pneumoniae at t = 18 h. (f) Soluble curcumin (8 µg/ml) and vancomycin (4 µg/ml) treated Klebsiella pneumoniae at t = 18 h. (g) Soluble curcumin (8 µg/ml) and vancomycin (8 µg/ml) treated Klebsiella pneumoniae at t = 18 h. (h) Soluble curcumin (8 µg/ml) and vancomycin (16 µg/ml) treated Klebsiella pneumoniae at t = 18 h.